North America Carcinoembryonic Antigen Market Size & Outlook
The carcinoembryonic antigen market in North America is expected to reach a projected revenue of US$ 1,276.4 million by 2030. A compound annual growth rate of 5.1% is expected of North America carcinoembryonic antigen market from 2024 to 2030.
Revenue, 2023 (US$M)
$901.6
Forecast, 2030 (US$M)
$1,276.4
CAGR, 2024 - 2030
5.1%
Report Coverage
North America
North America carcinoembryonic antigen market, 2018-2030 (US$M)
North America carcinoembryonic antigen market highlights
- The North America carcinoembryonic antigen market generated a revenue of USD 901.6 million in 2023.
- The market is expected to grow at a CAGR of 5.1% from 2024 to 2030.
- In terms of segment, colorectal cancer was the largest revenue generating type in 2023.
- Colorectal Cancer is the most lucrative type segment registering the fastest growth during the forecast period.
North America data book summary
| Market revenue in 2023 | USD 901.6 million |
| Market revenue in 2030 | USD 1,276.4 million |
| Growth rate | 5.1% (CAGR from 2023 to 2030) |
| Largest segment | Colorectal cancer |
| Fastest growing segment | Colorectal Cancer |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Colorectal Cancer |
Other key industry trends
- In terms of revenue, North America region accounted for 43.9% of the global carcinoembryonic antigen market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 713.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Carcinoembryonic Antigen Market Scope
Carcinoembryonic antigen market segmentation & scope
Gender
Male
Female
Product
CD66a
CD66b
CD66c
CD66d
CD66e
CD66f
Test
Molecular Tests
Serology Tests
End-use
Hospitals
Laboratories
Others
Countries
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait
Carcinoembryonic Antigen Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America carcinoembryonic antigen market
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
